Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Havard

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Drugs|August 1, 1983
Myasthenia gravis. Pathogenesis and current concepts in managementC W Havard, G K Scadding
Recenti Progressi in Medicina|January 1, 1977
[Myasthenia gravis]C W Havard, M J Lange
British Journal of Clinical Pharmacology|August 1, 1976
Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugsR M Pearson, C W Havard
British Medical Journal (Clinical Research Ed.)|October 17, 1981
Pathogenesis and treatment of myasthenia gravisG K Scadding, C W Havard
Clinical Endocrinology|October 1, 1978
Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal womenA J Isaacs, C W Havard
British Journal of Clinical Pharmacology|May 1, 1978
Intravenous labetalol in hypertensive patients given by fast and slow injectionR M Pearson, C W Havard
The British Journal of Clinical Practice|April 1, 1971
Safprin and gastrointestinal bleedingV F Saldanha, C W Havard
European Journal of Clinical Pharmacology|November 16, 1978
A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertensionE B Resnekov, C W Havard
British Journal of Hospital Medicine|October 1, 1978
Treatment of severe and resistant hypertensionR M Pearson, C W Havard
Thorax|May 1, 1973
Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectorisN K Sood, C W Havard
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Drugs|August 1, 1983
Myasthenia gravis. Pathogenesis and current concepts in managementC W Havard, G K Scadding
Recenti Progressi in Medicina|January 1, 1977
[Myasthenia gravis]C W Havard, M J Lange
British Journal of Clinical Pharmacology|August 1, 1976
Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugsR M Pearson, C W Havard
British Medical Journal (Clinical Research Ed.)|October 17, 1981
Pathogenesis and treatment of myasthenia gravisG K Scadding, C W Havard
Clinical Endocrinology|October 1, 1978
Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal womenA J Isaacs, C W Havard
British Journal of Clinical Pharmacology|May 1, 1978
Intravenous labetalol in hypertensive patients given by fast and slow injectionR M Pearson, C W Havard
The British Journal of Clinical Practice|April 1, 1971
Safprin and gastrointestinal bleedingV F Saldanha, C W Havard
European Journal of Clinical Pharmacology|November 16, 1978
A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertensionE B Resnekov, C W Havard
British Journal of Hospital Medicine|October 1, 1978
Treatment of severe and resistant hypertensionR M Pearson, C W Havard
Thorax|May 1, 1973
Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectorisN K Sood, C W Havard
Pageof 10